CDTX - Cidara Therapeutics GAAP EPS of -$0.26 revenue of $7.2M March, 07 2022 06:07 PM Cidara Therapeutics Inc. Cidara Therapeutics press release (NASDAQ:CDTX): Q4 GAAP EPS of -$0.26. Revenue of $7.2M (+94.6% Y/Y). For further details see: Cidara Therapeutics GAAP EPS of -$0.26, revenue of $7.2M